Skip to main content

UBS Group AG

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in AXSM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$37,181,297
-$55,305,601 QoQ
Shares Held
151,903
-72.2% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 503 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. AXSM ranks #45 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AXSM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,181,297 151,903
2026-03-31 $92,486,898 547,195
2025-12-31 $64,895,278 355,318
2025-09-30 $25,802,172 212,451
2025-06-30 $62,159,546 595,455
2025-03-31 $33,664,896 288,647
2024-12-31 $12,467,028 147,347
2024-09-30 $4,292,370 47,762
2024-06-30 $3,196,171 39,704
2024-03-31 $4,893,335 61,320
2023-12-31 $3,193,547 40,125
2023-09-30 $2,291,273 32,784
2023-06-30 $1,047,646 14,579
2023-03-31 $1,003,594 16,271
2022-12-31 $1,007,086 13,057
2022-09-30 $816,590 18,301
2022-06-30 $551,021 14,387
2022-03-31 $678,423 16,391
2021-12-31 $114,624 3,034
2021-09-30 $308,043 9,346
2021-06-30 $754,337 11,182
2021-03-31 $534,719 9,444
2020-12-31 $726,223 8,914
2020-09-30 $958,525 13,453
2020-06-30 $1,412,335 17,165
2020-03-31 $1,232,900 20,957